DES and rhabdomyosarcoma: Desmin and myogenin immunoreactivity can be used to differentiate rhabdomyosarcoma from other round cell tumors without rhabdomyoblastic differentiation but not sarcomatoid carcinoma with rhabdomyoblastic differentiation.